Every year, antibiotic-resistant Staphylococcus aureus, commonly known as staph, causes serious infections and outbreaks in ...
People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while certain bacteria may help to prevent S. aureus colonization. These are the ...
A naturally derived molecule shows promise in blocking critical behaviors that bacteria rely on to cause disease.
Dublin, July 14, 2025 (GLOBE NEWSWIRE) -- The "Methicillin-resistant Staphylococcus Aureus (MRSA) Epidemiology Forecast 2025-2034" report has been added to ResearchAndMarkets.com's offering. Studies ...
Hidden bacterial tactics: Studies show pathogens like E. coli and Staphylococcus aureus split into subpopulations with different survival strategies, making infections harder to treat. New treatment ...
Initial studies of staphylococcal adhesion focused on binding to the extracellular matrix and plasma proteins. More recently, studies have investigated adhesins for human keratinocytes and their ...
US FDA grants Fast Track Designation to Armata Pharma’s intravenously administered S. aureus multi-phage product candidate, AP-SA02: Los Angeles Friday, May 8, 2026, 12:00 Hrs [ ...
Researchers provide the first insight into the mode of action of the lipopeptide serrawettin W2-FL10, derived from Serratia marcescens. This lipopeptide targets the cell membrane of S. aureus, causing ...
Around 20 percent of all humans are persistently colonized with Staphylococcus aureus bacteria, a leading cause of skin infections and one of the major sources of hospital-acquired infections, ...